World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
29263
World Ranking
17867
National Ranking
937

Overview

Norbert Gattermann is affiliated with Heinrich Heine University Düsseldorf in Germany and has a research focus primarily in Medicine, with extensive contributions to Hematology, Genetics, Oncology, Molecular Biology, and Immunology.

The main topics covered in Gattermann's research include:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Hematological disorders and diagnostics
  • Hemoglobinopathies and Related Disorders
  • Neutropenia and Cancer Infections

Gattermann's publication record includes involvement in a number of highly specialized venues. The most frequent publication outlets are:

  • Blood
  • Cancers
  • Annals of Hematology
  • Leukemia Research
  • Deutsches Ärzteblatt international

Selected recent papers authored or co-authored by Gattermann include:

  • The evaluation of iron deficiency and iron overload, 2021, Deutsches Ärzteblatt international
  • Molecular International Prognostic Scoring System for Myelodysplastic Syndromes, 2022, NEJM Evidence
  • Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial, 2021, Leukemia
  • Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study, 2020, European Journal of Endocrinology
  • A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study, 2022, The Lancet Haematology

Frequent collaborators include researchers such as Ulrich Germing, Kathrin Nachtkamp, Annika Kasprzak, Rainer Haas, and Guido Kobbe, with collaboration counts ranging from 10 to 27 publications.

The breadth of Gattermann's research is evidenced by a substantial number of publications-over 140 in total-with a strong focus on hematological diseases, especially leukemia and related disorders. This body of work spans diagnosis, treatment, and molecular mechanisms underlying these conditions.

Best Publications

  • Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

    Brian J. Druker;François Guilhot;Stephen G. O'brien;Insa Gathmann

  • Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

    Pierre Fenaux;Ghulam J. Mufti;Eva Hellstrom-Lindberg;Valeria Santini

  • Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

    Pierre Fenaux;Ghulam J. Mufti;Eva Hellström-Lindberg;Valeria Santini

  • Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance

    Hagop M. Kantarjian;Francis Giles;Norbert Gattermann;Kapil Bhalla

  • Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

    Luca Malcovati;Eva Hellström-Lindberg;David Bowen;Lionel Adès

  • Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results

    Hagop M. Kantarjian;Francis J. Giles;Kapil N. Bhalla;Javier A. Pinilla-Ibarz

  • The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia

    Ross L. Levine;Marc Loriaux;Brian J. P. Huntly;Mignon L. Loh

  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Elsa Bernard;Yasuhito Nannya;Robert P. Hasserjian;Sean M. Devlin

  • Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients

    Ulrich Germing;Norbert Gattermann;Corinna Strupp;Manuel Aivado

  • Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.

    Aul C;Gattermann N;Heyll A;Germing U

  • Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid.

    Andrea Kuendgen;Corinna Strupp;Manuel Aivado;Alf Bernhardt

  • Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

    Maria Domenica Cappellini;John Porter;Amal El-Beshlawy;Chi Kong Li

  • Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia

    Philipp Le Coutre;Oliver G. Ottmann;Francis Giles;Dong Wook Kim

  • Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study

    John Porter;Renzo Galanello;Giuseppe Saglio;Ellis E.J. Neufeld

  • Age-related incidence and other epidemiological aspects of myelodysplastic syndromes

    C. Aul;N. Gattermann;W. Schneider

  • Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

    A Hochhaus;T Masszi;F J Giles;J P Radich

  • Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study

    F. J. Giles;P. D. Le Coutre;J. Pinilla-Ibarz;R. A. Larson

  • Heteroplasmic Point Mutations of Mitochondrial DNA Affecting Subunit I of Cytochrome c Oxidase in Two Patients With Acquired Idiopathic Sideroblastic Anemia

    Norbert Gattermann;Stefan Retzlaff;Yan-Ling Wang;Götz Hofhaus

  • Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value.

    Alexander E. Smith;Azim M. Mohamedali;Austin Kulasekararaj;ZiYi Lim

  • Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells

    S. Geyh;S. Öz;R. P. Cadeddu;J. Fröbel

Frequent Co-Authors

Ulrich Germing
Ulrich Germing Heinrich Heine University Düsseldorf
Aristoteles Giagounidis
Aristoteles Giagounidis Heinrich Heine University Düsseldorf
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Francis J. Giles
Francis J. Giles Northwestern University
Pierre Fenaux
Pierre Fenaux Université Paris Cité
Giuseppe Saglio
Giuseppe Saglio University of Turin
Ghulam J. Mufti
Ghulam J. Mufti King's College London
Guillermo Sanz
Guillermo Sanz Hospital Universitari i Politècnic La Fe
Oliver G. Ottmann
Oliver G. Ottmann Cardiff University
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the world of medicine doesn’t stop with becoming a physician. A wide range of online degrees related to healthcare have expanded career options for students and working professionals. Programs like cheap online dnp programs allow registered nurses to advance their careers affordably and flexibly. These programs are ideal for those seeking leadership roles in clinical practice or academia.

If you’re interested in pharmacy, you can now find pharmacy school online accredited options. These offer rigorous training and meet national accreditation standards, preparing graduates for licensure and patient care responsibilities.

The demand for skilled professionals in digital health records is growing rapidly. Earning a health information technology online degree can open doors to roles in data management, cybersecurity, and compliance within healthcare systems.

For those looking to enter the administrative side of healthcare, getting a medical billing and coding certification cost can provide a quick and affordable entry point. These certifications are ideal for remote work and addressing the growing need for accurate medical recordkeeping.

Best Scientists Citing Norbert Gattermann

Trending Scientists

Recently Published Articles